PureTech Health PLC (NAS:PRTC)
$ 24.53 -1.37 (-5.29%) Market Cap: 598.64 Mil Enterprise Value: 330.27 Mil PE Ratio: 0 PB Ratio: 1.34 GF Score: 53/100

Half Year 2021 PureTech Health PLC Earnings Call Transcript

Aug 24, 2021 / 01:00PM GMT
Release Date Price: $47.53 (+1.24%)
Operator

Greetings and welcome to the PureTech Health 2021 Half Year Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Allison Mead Talbot, Head of Communications. Thank you. Allison, you may now begin.

Allison Mead Talbot
PureTech Health plc - Head of Communications & IR

Thank you for joining us today for PureTech 2021 Half Year Results Webcast. The press release and report we issued earlier this morning, along with slides, can be found on the Investor Relations portion of our website at puretechhealth.com. Our half year report has also been filed with the SEC and is available on the SEC website. PureTech is a biotechnology company based in Boston, and we are dedicated to the development of novel therapeutics for the treatment of serious conditions with significant medical needs.

Today, I'm pleased to be joined by the senior team, including Daphne Zohar, Founder and Chief Executive Officer; Bharatt Chowrira, President and Chief of Business and Strategy; George

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot